Success Story: I-140 EB1B Approval Secured for a Researcher from China After NOID and Premium Processing Upgrade

Posted by wegreened on January 30, 2026 in EB1 Green Card, Pharmaceutical Sciences

Client’s Testimonial:

“I appreciate the attorney’s full support regarding my decision on the NOID, thank you for the prompt and professional suggestions throughout the evidence collection and letter drafting processes”

On April 1^st, 2025, we received another EB-1B (Outstanding Professors and Researchers) approval for a Researcher in the Field of Pharmaceutical Science (Approval Notice).

General Field: Pharmaceutical Science

Position at the Time of Case Filing: Researcher

Country of Origin: China

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: April 1^st, 2025

Processing Time: 25 months, 11 days (Premium Processing Requested)

Case Summary:

At North America Immigration Law Group, we are proud to highlight another EB1B success story demonstrating the power of persistence and strategic advocacy. We recently secured EB1B (Outstanding Researcher/Professor) approval for a Chinese researcher, whose case was initially challenged with a Notice of Intent to Deny (NOID) and later approved after a Premium Processing upgrade after 25 months and 11 days.

Our client, currently employed in the U.S. at a major academic institution, specializes in pharmaceutical material science and drug formulation, with impactful research in enhancing drug solubility, modernizing traditional herbal medicine, and improving pharmaceutical delivery systems. Her work contributes directly to drug design innovations and public health outcomes, aligning with critical national interests in medical research and pharmaceutical development.

To demonstrate her eligibility under the EB1B classification, we submitted a compelling petition that highlighted the following:

Publications and Citations: Our client has authored 15 peer-reviewed scientific articles, with 215 citations to date. Several of her publications ranked among the top 10% most-cited in Pharmacology & Toxicology for their year.

Peer Review Contributions: She has completed at least 10 peer reviews for top journals, including the International Journal of Pharmaceutics and Molecular Pharmaceutics, reinforcing her expert standing.

Significance and Impact: Her research has been cited by independent scholars across six continents and applied in areas such as drug delivery, stroke treatment, and pharmaceutical formulation. Letters from internationally recognized experts further confirmed her contributions as original, influential, and highly regarded in the field.

Even with the challenge of a NOID, we successfully demonstrated our client’s international recognition and major scientific impact, criteria central to the EB1B category. We’re thrilled to celebrate this hard-earned approval and proud to support her continued contributions to pharmaceutical innovation in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%